Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Jul;59(7):2364–2369. doi: 10.1128/iai.59.7.2364-2369.1991

Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V.

J Haber 1, C M Grinnell 1, J E Beem 1, W B Clark 1
PMCID: PMC258019  PMID: 1675628

Abstract

Antibodies reactive with type 1 and type 2 fimbriae from Actinomyces viscosus T14V specifically inhibit the adherence of A. viscosus T14V to salivary pellicle-coated tooth surfaces and other bacteria, and these antibodies are thought to modulate colonization by this microorganism. These studies were done to determine whether previously noted differences in the antibody responses of inbred mice to type 1 and type 2 fimbriae might be under genetic control. The serum immunoglobulin G (IgG) and IgM antibody responses of inbred, F1 hybrid, and H-2 congenic mice, immunized with A. viscosus T14V cells, were analyzed by enzyme-linked immunosorbent assays for antibodies reactive with A. viscosus T14V whole-cell type 1 and type 2 fimbriae. The results confirmed earlier findings and indicated striking variations in the amounts of IgG anti-type 1 (23-fold) and anti-type 2 (48-fold) fimbria antibodies elicited. The responses of the 17 inbred strains tested showed a relatively continuous distribution from high to low, as well as marked differences in the responses of H-2 and Igh-C identical strain pairs. An analysis of the responses of F1 hybrid and H-2 congenic mice indicated dominance of the low-responder gene(s) and control by H-2-linked genes. Antisera from two high-responder strains inhibited in vitro bacterial adherence to a much greater degree than antisera from a low-responding strain. These data suggest polygenic control of the magnitude of the IgG anti-type 1 and anti-type 2 fimbria antibody responses by H-2-linked genes as well as background genes not associated with H-2 or Igh-C loci.

Full text

PDF
2364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andó I., Fachet J. Genetic control of two different types of antibody responses to oxazolone. Eur J Immunol. 1977 Aug;7(8):516–519. doi: 10.1002/eji.1830070805. [DOI] [PubMed] [Google Scholar]
  2. Babbitt B. P., Allen P. M., Matsueda G., Haber E., Unanue E. R. Binding of immunogenic peptides to Ia histocompatibility molecules. 1985 Sep 26-Oct 2Nature. 317(6035):359–361. doi: 10.1038/317359a0. [DOI] [PubMed] [Google Scholar]
  3. Baker P. J., Bailey D. W., Fauntleroy M. B., Stashak P. W., Caldes G., Prescott B. Genes on different chromosomes influence the antibody response to bacterial antigens. Immunogenetics. 1985;22(3):269–276. doi: 10.1007/BF00404486. [DOI] [PubMed] [Google Scholar]
  4. Beachey E. H. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis. 1981 Mar;143(3):325–345. doi: 10.1093/infdis/143.3.325. [DOI] [PubMed] [Google Scholar]
  5. Benacerraf B. Role of MHC gene products in immune regulation. Science. 1981 Jun 12;212(4500):1229–1238. doi: 10.1126/science.6165083. [DOI] [PubMed] [Google Scholar]
  6. Bienenstock J., Befus A. D. Mucosal immunology. Immunology. 1980 Oct;41(2):249–270. [PMC free article] [PubMed] [Google Scholar]
  7. Briles D. E., Perlmutter R. M., Hansburg D., Little J. R., Davie J. M. Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus-dependent antigens. Eur J Immunol. 1979 Apr;9(4):255–261. doi: 10.1002/eji.1830090402. [DOI] [PubMed] [Google Scholar]
  8. Cinader B., Koh S. W., Naylor D. Tolerance-mediated inheritance of immune responsiveness. Int Arch Allergy Appl Immunol. 1969;35(2):150–162. doi: 10.1159/000230168. [DOI] [PubMed] [Google Scholar]
  9. Cisar J. O., Kolenbrander P. E., McIntire F. C. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect Immun. 1979 Jun;24(3):742–752. doi: 10.1128/iai.24.3.742-752.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cisar J. O., Sandberg A. L., Mergenhagen S. E. The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii. J Dent Res. 1984 Mar;63(3):393–396. doi: 10.1177/00220345840630030701. [DOI] [PubMed] [Google Scholar]
  11. Cisar J. O., Vatter A. E. Surface fibrils (fimbriae) of Actinomyces viscosus T14V. Infect Immun. 1979 May;24(2):523–531. doi: 10.1128/iai.24.2.523-531.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clark W. B., Wheeler T. T., Cisar J. O. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae. Infect Immun. 1984 Feb;43(2):497–501. doi: 10.1128/iai.43.2.497-501.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Debré P., Kapp J. A., Benacerraf B. Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. J Exp Med. 1975 Dec 1;142(6):1436–1446. doi: 10.1084/jem.142.6.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Donkersloot J. A., Cisar J. O., Wax M. E., Harr R. J., Chassy B. M. Expression of Actinomyces viscosus antigens in Escherichia coli: cloning of a structural gene (fimA) for type 2 fimbriae. J Bacteriol. 1985 Jun;162(3):1075–1078. doi: 10.1128/jb.162.3.1075-1078.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Elson C. O., Ealding W. Genetic control of the murine immune response to cholera toxin. J Immunol. 1985 Aug;135(2):930–932. [PubMed] [Google Scholar]
  16. Freed J. H., Deak B. D., McDevitt H. O. Mapping of the genetic control of murine response to low doses of the dinitrophenyl conjugates of ovomucoid and bovine gamma-globulin. J Immunol. 1976 Nov;117(5 Pt 1):1514–1518. [PubMed] [Google Scholar]
  17. Gasser D. L. Genetic control of the immune response in mice. I. Segregation data and localization to the fifth linkage group of a gene affecting antibody production. J Immunol. 1969 Jul;103(1):66–70. [PubMed] [Google Scholar]
  18. Gibbons R. J. Adherent interactions which may affect microbial ecology in the mouth. J Dent Res. 1984 Mar;63(3):378–385. doi: 10.1177/00220345840630030401. [DOI] [PubMed] [Google Scholar]
  19. Haber J., Grinnell C. Analysis of the serum antibody responses to type 1 and type 2 fimbriae in mice immunized with Actinomyces viscosus T14V. J Periodontal Res. 1989 Mar;24(2):81–87. doi: 10.1111/j.1600-0765.1989.tb00861.x. [DOI] [PubMed] [Google Scholar]
  20. Haber J., Winn H. J. Genetic control of the expression of immunoglobulin isotypes in the responses of mice to sheep red blood cells. Eur J Immunol. 1981 Sep;11(9):671–678. doi: 10.1002/eji.1830110902. [DOI] [PubMed] [Google Scholar]
  21. Holmes K. L., Palfree R. G., Hammerling U., Morse H. C., 3rd Alleles of the Ly-17 alloantigen define polymorphisms of the murine IgG Fc receptor. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7706–7710. doi: 10.1073/pnas.82.22.7706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Keck K. Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinant. Nature. 1975 Mar 6;254(5495):78–79. doi: 10.1038/254078a0. [DOI] [PubMed] [Google Scholar]
  23. Kimura S., Tada N., Nakayama E., Liu Y., Hämmerling U. A new mouse cell-surface antigen (Ly-m20) controlled by a gene linked to Mls locus and defined by monoclonal antibodies. Immunogenetics. 1981;14(1-2):3–14. doi: 10.1007/BF00344295. [DOI] [PubMed] [Google Scholar]
  24. Kipp D. E., Furman A., Miller A., Sercarz E. E. Delayed advent of stringent, non-H-2 genetic regulation of the antibody response to a protein antigen. J Immunol. 1979 Oct;123(4):1709–1714. [PubMed] [Google Scholar]
  25. Loesche W. J., Syed S. A. Bacteriology of human experimental gingivitis: effect of plaque and gingivitis score. Infect Immun. 1978 Sep;21(3):830–839. doi: 10.1128/iai.21.3.830-839.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mett H., Kloetzlen L., Vosbeck K. Fimbria-specific antibodies detach Escherichia coli from human cells. Infect Immun. 1983 Jun;40(3):862–868. doi: 10.1128/iai.40.3.862-868.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pisetsky D. S., Berzofsky J. A., Sachs D. H. Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H2-linked genes in the control of the anti-nuclease antibody response. J Exp Med. 1978 Feb 1;147(2):396–408. doi: 10.1084/jem.147.2.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Revis G. J., Vatter A. E., Crowle A. J., Cisar J. O. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence. Infect Immun. 1982 Jun;36(3):1217–1222. doi: 10.1128/iai.36.3.1217-1222.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Riblet R., Blomberg B., Weigert M., Lieberman R., Taylor B. A., Potter M. Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol. 1975 Nov;5(11):775–777. doi: 10.1002/eji.1830051109. [DOI] [PubMed] [Google Scholar]
  30. Riley R. L., Wilson L. D., Germain R. N., Benjamin D. C. Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin. J Immunol. 1982 Oct;129(4):1553–1558. [PubMed] [Google Scholar]
  31. Silver D. M., Lane D. P. Dominant nonresponsiveness in the induction of autoimmunity to liver-specific F antigen. J Exp Med. 1975 Dec 1;142(6):1455–1461. doi: 10.1084/jem.142.6.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Syed S. A., Loesche W. J. Bacteriology of human experimental gingivitis: effect of plaque age. Infect Immun. 1978 Sep;21(3):821–829. doi: 10.1128/iai.21.3.821-829.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vidović D., Matzinger P. Unresponsiveness to a foreign antigen can be caused by self-tolerance. Nature. 1988 Nov 17;336(6196):222–225. doi: 10.1038/336222a0. [DOI] [PubMed] [Google Scholar]
  34. Wheeler T. T., Clark W. B., Birdsell D. C. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo. Infect Immun. 1979 Sep;25(3):1066–1074. doi: 10.1128/iai.25.3.1066-1074.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wheeler T. T., Clark W. B. Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite. Infect Immun. 1980 May;28(2):577–584. doi: 10.1128/iai.28.2.577-584.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yeung M. K., Chassy B. M., Cisar J. O. Cloning and expression of a type 1 fimbrial subunit of Actinomyces viscosus T14V. J Bacteriol. 1987 Apr;169(4):1678–1683. doi: 10.1128/jb.169.4.1678-1683.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zinkernagel R. M., Doherty P. C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974 Apr 19;248(5450):701–702. doi: 10.1038/248701a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES